Drugmaker Abbott says not pursuing an offer for St Jude Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Boston Scientific discloses cybersecurity incident causing global disruption
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Deutsche Bank Has Mixed View of Hypothetical Abbott Labs (ABT) & St. Jude Medical (STJ) Deal
August 27, 2015 11:42 AM EDTDeutsche Bank analyst Kristen Stewart said she was "somewhat mixed" on a potential Abbott Labs (NYSE: ABT) and St. Jude Medical (NYSE: STJ) deal. Earlier rumors from the Financial Times said Abbott was preparing a $25 billion offer for St. Jude, but the speculation was later denied by Abbott in a statement to Bloomberg. Stewart questioned if buying St. Jude would be the most efficient use of capital.
"We believe that with the addition of STJ, ABT's Medical Device division and more specifically its vascular franchise, would be... More
